Allstate Trades Above 50-Day SMA: How to Play the Stock Now?

05.09.25 19:04 Uhr

Werte in diesem Artikel
Aktien

178,25 EUR -0,20 EUR -0,11%

Indizes

PKT PKT

17.981,6 PKT -69,5 PKT -0,39%

6.715,8 PKT 0,4 PKT 0,01%

The Allstate Corporation ALL has been trading above its 50-day simple moving average (SMA), signaling a short-term bullish trend.The 50-day SMA is a key indicator for traders and analysts to identify support and resistance levels. It is considered particularly important as this is the first marker of an uptrend or downtrend.Allstate, the third-largest property-casualty insurer and the largest publicly-held personal lines carrier in the United States, is poised to deliver growth banking on growing premiums, business streamlining and solid cash flows.Price Performance of ALLShares of ALL have gained 8.1%  in the year-to-date period compared with the industry’s growth of 10.6%. The Finance sector and the Zacks S&P 500 Composite have increased 13.3% and 11.1%, respectively, in the same time frame.The insurer has a market capitalization of $54.9 billion. The average volume of shares traded in the last three months was 1.6 million. Image Source: Zacks Investment ResearchALL Shares Are ExpensiveShares of Allstate are trading at a premium compared with the industry. Its price-to-book value of 2.5X is higher than the industry average of 1.58X. Image Source: Zacks Investment ResearchHowever, shares of Chubb Limited CB are trading at a multiple lower than the industry average, whileshares of The Progressive Corporation PGR and The Travelers Companies, Inc. TRV are trading at a premium.Projections for ALLThe Zacks Consensus Estimate for ALL’s 2025 earnings per share (EPS) is pegged at $21.19, and the same for revenues is pegged at $69 billion. The consensus estimate for 2026 earnings per share and revenues indicates a rise of 7.7% and 5.4%, respectively, from the corresponding 2025 estimates. The expected long-term earnings are pegged at 11.8%, better than the industry average of 7%. It has a Growth Score of BOptimistic Analyst Sentiment for ALLThe Zacks Consensus Estimate for 2025 earnings has moved up 1.2% in the past seven days, while the same for 2026 has moved up 0.04% in the same time frame. Image Source: Zacks Investment ResearchAverage Target Price for ALL Suggests UpsideBased on short-term price targets offered by 19 analysts, the Zacks average price target is $231.21 per share. The average suggests a potential 13.7% upside from the last closing price. Image Source: Zacks Investment ResearchKey Points for ALLAllstate’s growth trajectory is being shaped by steady expansion in premiums, supported by targeted acquisitions and new business ventures. By sharpening its core operations, the company has been able to channel resources into higher-growth segments while implementing cost efficiencies to protect margins. Strong cash flow generation further strengthens its ability to reward shareholders, underscoring a balanced approach to profitability and expansion.Allstate continues to record healthy revenue gains, with premium growth serving as the primary engine. The first half of 2025 saw an 8.1% jump from the prior year, and a similar 8% increase is anticipated for the full year. This strength reflects a balanced mix of disciplined pricing, portfolio diversification, and selective acquisitions.Alongside premium growth, Allstate is broadening its reach by scaling protection services and strengthening its property-liability business. Its vast policy base, trusted brand, and expanding offerings, ranging from identity protection to roadside assistance, create multiple avenues for growth. Combined with disciplined capital management, these initiatives reinforce long-term value creation for the business and its shareholders.Looking ahead, management’s focus on rate revisions, product upgrades, and a pivot toward more profitable segments is expected to extend the momentum. Importantly, inflation-driven cost pressures are being countered through further pricing actions, ensuring that revenue expansion remains on track.Despite steady growth, Allstate continues to face several challenges. Exposure to catastrophe-related losses and a relatively high debt burden weigh on its financials, while inflationary pressures and supply chain disruptions have pushed up claims and repair costs. The rising complexity of vehicle technology has further driven up replacement expenses. Even with reinsurance support, severe weather events have strained underwriting results, pressuring both profitability and cash flows.In addition, the company’s elevated leverage remains a concern. Allstate’s debt-to-capital ratio stood at 25.2%, higher than the industry average of 16.1%, reflecting a comparatively leveraged balance sheet. While its times interest earned ratio of 19 is stronger than the industry’s 17, any disruption in earnings could strain debt servicing, deteriorate credit strength, and add further pressure to overall financial stability.ConclusionOverall, Allstate demonstrates solid revenue momentum, disciplined pricing, and strategic expansion into higher-growth services. However, elevated leverage, catastrophe-related exposure, and rising cost pressures temper the outlook.Given the overvaluation, it is therefore wise to adopt a wait-and-see approach on this Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Travelers Companies, Inc. (TRV): Free Stock Analysis Report Chubb Limited (CB): Free Stock Analysis Report The Allstate Corporation (ALL): Free Stock Analysis Report The Progressive Corporation (PGR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Allstate und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Allstate

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Allstate

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Allstate Corp.

Wer­bung

Analysen zu Allstate Corp.

DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
03.04.2017Allstate Mkt PerformFBR & Co.
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
04.08.2015Allstate OverweightBarclays Capital
DatumRatingAnalyst
03.04.2017Allstate Mkt PerformFBR & Co.
05.08.2015Allstate NeutralCompass Point
04.08.2015Allstate Sector PerformRBC Capital Markets
07.05.2015Allstate NeutralCompass Point
31.10.2014Allstate NeutralCompass Point
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Allstate Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen